Core Viewpoint - Jianerkang, a company specializing in disposable medical devices and disinfectant hygiene products, is set to be listed on the Shanghai Stock Exchange on November 7, 2024, showcasing its technological and production advantages in the industry [1] Group 1: Business Performance - In Q3 2025, Jianerkang reported revenue of 725 million yuan, ranking 28th out of 50 in the industry, below the industry average of 1.379 billion yuan and the median of 755 million yuan [2] - The company's net profit for the same period was approximately 76.41 million yuan, ranking 24th in the industry, higher than the median of 75.88 million yuan but lower than the average of 183 million yuan [2] Group 2: Financial Ratios - Jianerkang's debt-to-asset ratio was 11.53% in Q3 2025, down from 15.47% in the previous year and below the industry average of 23.66%, indicating strong solvency [3] - The gross profit margin for the same period was 24.28%, an increase from 22.88% year-on-year, but still below the industry average of 48.78% [3] Group 3: Shareholder Information - As of September 30, 2025, the number of A-share shareholders decreased by 6.15% to 17,100, while the average number of circulating A-shares held per shareholder increased by 38.51% to 2,286.59 [5] - The largest circulating shareholder is the Medical Device ETF (159883), which holds 285,100 shares as a new shareholder [5] Group 4: Executive Compensation - The chairman and general manager, Chen Guoping, received a salary of 1.1473 million yuan in 2024, an increase of 15,400 yuan from 2023 [4]
健尔康的前世今生：2025年三季度营收7.25亿低于行业平均，净利润7640.96万高于中位数